Xunfei Healthcare Technology Co., Ltd. (HKG:2506)
Hong Kong
· Delayed Price · Currency is HKD
108.00
+0.50 (0.47%)
Last updated: Apr 22, 2025
HKG:2506 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Revenue | 733.98 | 556.13 | 471.86 | 372.45 |
| Revenue Growth (YoY) | 31.98% | 17.86% | 26.69% | - |
| Cost of Revenue | 329.9 | 241.47 | 241.19 | 184.72 |
| Gross Profit | 404.08 | 314.65 | 230.67 | 187.73 |
| Selling, General & Admin | 287.99 | 275.62 | 269.27 | 160 |
| Research & Development | 271.89 | 263.96 | 241.58 | 159.79 |
| Operating Expenses | 572.27 | 545.41 | 519.6 | 319.94 |
| Operating Income | -168.19 | -230.75 | -288.93 | -132.21 |
| Interest Expense | -6.14 | -1.21 | -0.59 | -2.9 |
| Interest & Investment Income | 6.42 | 7.96 | 3.14 | 1.81 |
| Other Non Operating Income (Expenses) | -4.43 | 36.22 | 39.55 | 22.47 |
| EBT Excluding Unusual Items | -172.34 | -187.79 | -246.84 | -110.83 |
| Gain (Loss) on Sale of Investments | 0.32 | 0.9 | 2.73 | - |
| Gain (Loss) on Sale of Assets | -0.02 | -0.03 | 0.01 | -0.14 |
| Other Unusual Items | 0.03 | - | - | - |
| Pretax Income | -172.02 | -186.92 | -244.1 | -110.97 |
| Income Tax Expense | -34.38 | -32.69 | -35.51 | -21.57 |
| Earnings From Continuing Operations | -137.64 | -154.22 | -208.6 | -89.4 |
| Minority Interest in Earnings | 5.04 | 9.38 | 19.2 | 5.69 |
| Net Income | -132.6 | -144.84 | -189.4 | -83.71 |
| Net Income to Common | -132.6 | -144.84 | -189.4 | -83.71 |
| Shares Outstanding (Basic) | 114 | 111 | 111 | 93 |
| Shares Outstanding (Diluted) | 114 | 111 | 111 | 93 |
| Shares Change (YoY) | 2.47% | 0.11% | 18.89% | - |
| EPS (Basic) | -1.16 | -1.30 | -1.71 | -0.90 |
| EPS (Diluted) | -1.16 | -1.30 | -1.71 | -0.90 |
| Free Cash Flow | -142.2 | -325.13 | -119.92 | -58.74 |
| Free Cash Flow Per Share | -1.25 | -2.93 | -1.08 | -0.63 |
| Gross Margin | 55.05% | 56.58% | 48.88% | 50.40% |
| Operating Margin | -22.91% | -41.49% | -61.23% | -35.50% |
| Profit Margin | -18.07% | -26.05% | -40.14% | -22.48% |
| Free Cash Flow Margin | -19.37% | -58.46% | -25.41% | -15.77% |
| EBITDA | -136.18 | -204.54 | -250.68 | -102.64 |
| EBITDA Margin | -18.55% | -36.78% | -53.13% | -27.56% |
| D&A For EBITDA | 32.01 | 26.21 | 38.26 | 29.57 |
| EBIT | -168.19 | -230.75 | -288.93 | -132.21 |
| EBIT Margin | -22.91% | -41.49% | -61.23% | -35.50% |
| Advertising Expenses | - | - | 8.14 | 3.44 |
Source: S&P Global Market Intelligence. Standard template.
Financial Sources.